UPDATE 1-U.S. jury orders Takeda to pay Bayer $155 mln over hemophilia drug
February 05, 2019 at 16:16 PM EST
A U.S. jury has ordered Takeda Pharmaceutical Co's Baxalta unit to pay Bayer AG $155.19 million for infringing a patent related to a Baxalta hemophilia treatment, court records made public on Tuesday show.
